Cleared Traditional

K812738 - BOUNDARY PROCESS CHANGE

K812738 is the FDA 510(k) clearance for BOUNDARY PROCESS CHANGE by The Buckeye Cellulose Corp.. It is a Class 2 General Hospital device (product code KKX) cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K812738 · The Buckeye Cellulose Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1981
Decision
48d
Days
Class 2
Risk

K812738 is an FDA 510(k) clearance for the BOUNDARY PROCESS CHANGE. Classified as Drape, Surgical (product code KKX), Class II - Special Controls.

Submitted by The Buckeye Cellulose Corp. (Mchenry, US). The FDA issued a Cleared decision on November 16, 1981 after a review of 48 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 878.4370 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Buckeye Cellulose Corp. devices

Submission Details

510(k) Number K812738 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 1981
Decision Date November 16, 1981
Days to Decision 48 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 129d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KKX Drape, Surgical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4370
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - KKX Drape, Surgical

All 162
Devices cleared under the same product code (KKX) and FDA review panel - the closest regulatory comparables to K812738.
SURGIKOS INCISE DRAPE
K820542 · Surgikos, Inc. · Jun 1982
CURITY PREMIUM CYSTOSCOPY TRAY
K820850 · The Kendal Co. · May 1982
ANAGO STERILE PRODUCTS
K813097 · Anago, Inc. · Mar 1982
STERILE ADHERENT DRAPES
K812809 · Abco Dealers, Inc. · Nov 1981
3M GERMICIDAL SURGICAL INCISE DRAPE
K801550 · 3M Company · Sep 1981
BACTERICIDAL INCISE DRAPE
K811871 · Surgikos, Inc. · Aug 1981